Montreal Cholesterol Summit

Thursday, May 30, 2019

RI MUHC - 1001 Decarie Blvd, Montreal, Quebec H4A 3J1
Drs. Sylvia & Richard Cruess Amphitheatre (ES1.1129)

The Montreal Cholesterol Summit will honor Dr. Nabil Seidah, for his contributions to cardiovascular disease research.  Dr. Seidah is a co-recipient of the 2018 Lucian Award at McGill University for his discovery of PCSK9.  An International panel of Speakers will discuss clinical trials of PCSK9, the New 2019 Canadian Cholesterol Guidelines, the genetics of lipoprotein disorders and the public policies of genetic diagnosis.

Click here to access Program

The symposium is open to residents and staff of McGill University and physicians. All participants must register in order to participate at the Montreal Cholesterol Summit. 

The deadline to register for the event is Monday, May 27, 2019

Click here to access the Registration Form

Click here to access the Evaluation Form (Coming Soon)

Learning objectives:

  • Understand the discovery of PCSK9 and its biological actions
  • Review the clinical trials of PCSK9 for the prevention and treatment of atherosclerotic cardiovascular diseases
  • Review the new Canadian Cholesterol Guidelines from the Canadian Cardiovascular Society
  • Understand the role of genetics in diagnosis and prognosis
  • Understand the ethical considerations in genetic testing

Practice outcomes:

  • An approach to the understanding of lipid disorders
  • The role of genetic testing
  • The ethical implications of genetic testing
  • Applying evidence-based medicine for the prevention of ASCVD

 


Contact:

Giorgina Ciavarella
1001 blvd. Decarie, Office C4.4180, Montreal, Quebec H4A 3J1
Tel: 514-934-1934 #34631
Email: giorgina.ciavarella [at] mcgill.ca